Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04784494 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MST for Parkinson's Disease

Study acronym: MST-PD
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Primary completion date changed from estimate of Oct 2023 to Jul 1, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2023 to Feb 2025
    • Site details revised
    v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2021 to Sep 20, 2021
    • Site details revised
    v4
  4. Start date: Aug 1, 2021 to Sep 1, 2021v3
  5. Phase: Phase 2 to Not applicable
    • Start date: Apr 1, 2021 to Aug 1, 2021
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial aims to test the feasibility of Magnetic Seizure Therapy (MST) for Depression in patients diagnosed with Parkinson's Disease.
Trial Details
NCT Number NCT04784494
Lead Sponsor University of British Columbia
Conditions
(from sponsor)		 Parkinson Disease, Depression, Movement Disorders, Major Depressive Disorder
Related terms Depression, Major Depressive Disorder, Movement Disorders, Parkinson Disease
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov